Utah has authorized an artificial intelligence system to issue first-time prescriptions on its own, a first for any U.S. state. Healthcare startup Nolla Health announced October 5, 2026, that its Nolla Derm app can now independently prescribe initial acne treatments to Utah adults, under a regulatory agreement signed September 22 with the state's Office of Artificial Intelligence Policy and Division of Professional Licensing.
How the AI prescriber works
Nolla Derm assesses acne through a five-angle smartphone face scan plus a 10-to-15-minute intake, then selects from eight pre-approved topical medications, including tretinoin, adapalene, clindamycin-benzoyl peroxide, benzoyl peroxide, azelaic acid, compounded niacinamide, and topical spironolactone. The AI cannot prescribe isotretinoin (Accutane) or any oral medication. The app costs $4.99 per month for Utah residents 18 and older with mild-to-moderate acne; compounded medications run $49.99 per month, or $10–40 for generics at a pharmacy.
The safety guardrails
The state agreement builds in a three-stage physician oversight ramp-down. For the first 100 patients, two Utah-licensed physicians review every prescription before it is issued. As volume grows, oversight shifts to weekly retrospective reviews and then monthly sampling of at least 10% of cases plus every adverse event — but only if the AI maintains at least 95% agreement with clinicians, misses no hard stops, and causes no serious adverse events. Built-in hard stops route severe cases to doctors: a severity score above 3.5 sends the case to physician review, and 4.0 requires an in-person dermatologist. Pregnancy, breastfeeding, patients under 18, non-Utah addresses, and immunosuppression are all routed out automatically. The severity model was trained on more than 100,000 labeled acne cases and agreed with clinicians' treatment picks in about 96% of its 1,000 most recent real-world treatments, according to the company's validation data.
Why Utah said yes
Access is the argument. Roughly 100,000 Utahns have active acne, but only about 10% ever see a dermatologist; the average wait for a dermatology appointment is 61 days, and 11 Utah counties have no dermatologist at all, while an in-person visit can cost $150–300. Utah already let AI renew prescriptions under earlier pilots — this is the first U.S. authorization for AI to issue an initial prescription. One nuance worth noting: the agreement grants regulatory mitigation, not a formal state endorsement of the product. "The Nolla Health pilot program represents a significant step forward in leveraging AI to improve health care access for Utahns, while maintaining rigorous oversight and safety," said Zach Boyd, director of Utah's Office of AI Policy. Nolla Health, founded by CEO Luis Wenus, raised $4.5 million in pre-seed funding and says its app has been downloaded more than 175,000 times across 44 states.
Takeaway: Utah just turned the hypothetical of AI doctors into a regulated pilot — the rest of the country will be watching the safety data.
Watch: Search YouTube for the latest video coverage of Nolla Health's Utah AI prescription approval.
Reel music: Kevin MacLeod - Electrodoodle (incompetech.com), licensed under CC BY 3.0
Sources: Medical Economics, Unite.AI, Becker's Hospital Review